Clinical Trials Directory

Trials / Completed

CompletedNCT05711108

Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities

Continuous Glucose Monitoring (CGM) to Assess Hypoglycemia in Older Adults With Diabetes in Long Term Care (LTC) Facilities

Status
Completed
Phase
Study type
Observational
Enrollment
86 (actual)
Sponsor
Joslin Diabetes Center · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

To prospectively determine the burden of hypoglycemia (minutes spent below 70 mg/dl per day, measured by continuous glucose monitor (CGM)) among residents of long term care facilities (LTC) with a diagnosis of type 1 or type 2 diabetes including key clinical subgroups (living in skilled nursing facility (SNF) or nursing home (NH), on different hypoglycemic medications). This aim will be achieved by recruiting 300 residents with diabetes in 4 LTC facilities. All participants will undergo masked CGM for 10 days.

Conditions

Timeline

Start date
2022-01-19
Primary completion
2024-11-30
Completion
2024-12-31
First posted
2023-02-02
Last updated
2025-10-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05711108. Inclusion in this directory is not an endorsement.